An in-depth look to EGETIS THERAPEUTICS AB operating, investing, and financing activities

EGTX free cash flow for Q3 24 is -62.5 M SEK. For 2023, EGTX free cash flow was -278.4 M SEK and operating cash flow was -278.4 M SEK.